Author details

Full Name

Guolian Kang

Affiliation

ORCID

Career Start Year

2006

Papers

131

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36860093	Attitudes toward COVID-19 vaccine among pediatric patients with sickle cell disease and their caregivers.	Pediatr Blood Cancer	2023
36200422	The effects of cardio-selective Î² blockade on diastolic dysfunction in children with sickle cell disease.	Haematologica	2023
35980301	Internalizing Symptoms in Adolescents With Sickle Cell Disease.	J Pediatr Psychol	2023
37695741	Intensive hydroxyurea dosing in very young children with sickle cell anemia.	Blood Adv	2023
37400614	Potent and uniform fetal hemoglobin induction via base editing.	Nat Genet	2023
37023228	Proinflammatory state promotes red blood cell alloimmunization in pediatric patients with sickle cell disease.	Blood Adv	2023
36890729	Longitudinal effect of disease-modifying therapy on left ventricular diastolic function in children with sickle cell anemia.	Am J Hematol	2023
36815529	Social determinants of neurocognitive and academic performance in sickle cell disease.	Pediatr Blood Cancer	2023
36993312	Genetic regulation of fetal hemoglobin across global populations.	medRxiv	2023
36861391	Health literacy correlates with abbreviated full-scale IQ in adolescent and young adults with sickle cell disease.	Pediatr Blood Cancer	2023
35303690	Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia<sup>â¿°,â¿°â¿°</sup>.	Curr Res Transl Med	2022
36356169	Assessment of transition readiness to predict health care utilization during transition to adult care in sickle cell disease.	Expert Rev Hematol	2022
36031725	Neurocognitive functioning in children with sickle cell anemia and history of abnormal transcranial doppler ultrasonography.	Pediatr Blood Cancer	2022
35643941	Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children.	Bone Marrow Transplant	2022
35380685	Adaptive Functioning in Children and Adolescents With Sickle Cell Disease.	J Pediatr Psychol	2022
36283106	IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms.	Blood	2022
35631651	Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease.	Pharmaceutics	2022
36338957	Editorial: Statistical methods, computing, and resources for genome-wide association studies, Volume II.	Front Genet	2022
35737751	Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.	Br J Haematol	2022
36202972	Murine foetal liver supports limited detectable expansion of life-long haematopoietic progenitors.	Nature Cell Biology	2022
34989462	Reading intervention targeting phonemic awareness and symbol imagery in children with sickle cell disease.	Pediatric Blood and Cancer	2022
35266368	GMEPS: a fast and efficient likelihood approach for genome-wide mediation analysis under extreme phenotype sequencing.	Stat Appl Genet Mol Biol	2022
34971013	Neurocognitive functioning in preschool children with sickle cell disease.	Pediatr Blood Cancer	2022
35180759	Enuresis and Hyperfiltration in Children With Sickle Cell Disease.	J Pediatr Hematol Oncol	2022
35147289	Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experience.	Pediatric Blood and Cancer	2022
34422016	Editorial: Statistical Methods, Computing and Resources for Genome-Wide Association Studies.	Front Genet	2021
35844692	Gabapentin for acute pain in sickle cell disease: A randomized double-blinded placebo-controlled phase II clinical trial.	EJHaem	2021
32107332	High bias and low precision for estimated versus measured glomerular filtration rate in pediatric sickle cell anemia.	Haematologica	2021
33855784	Eltrombopag in children with severe aplastic anemia.	Pediatr Blood Cancer	2021
34283174	A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease.	Blood Adv	2021
34272726	Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood.	Br J Haematol	2021
33570630	Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.	Blood Adv	2021
33570182	Cognitive performance as a predictor of healthcare transition in sickle cell disease.	Br J Haematol	2021
34137022	Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anaemia: SCCRIP cohort study results.	Br J Haematol	2021
34331507	Effects of hydroxyurea on brain function in children with sickle cell anemia.	Pediatr Blood Cancer	2021
34131902	What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study.	Br J Haematol	2021
33093339	Pain in Youth With Sickle Cell Disease: A Report From the Sickle Cell Clinical Research and Intervention Program.	Clin J Pain	2021
33119199	Role of implicit bias in pediatric cancer clinical trials and enrollment recommendations among pediatric oncology providers.	Cancer	2021
34407676	Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia.	Exp Biol Med (Maywood)	2021
34396511	Developmental screening of three-year-old children with sickle cell disease compared to controls.	British Journal of Haematology	2021
34966350	Academic Performance of Children With Sickle Cell Disease in the United States: A Meta-Analysis.	Front Neurol	2021
30945605	Extreme-value sampling design is cost-beneficial only with a valid statistical approach for exposure-secondary outcome association analyses.	Statistical Methods in Medical Research	2020
32027737	GPRASP proteins are critical negative regulators of hematopoietic stem cell transplantation.	Blood	2020
32266139	Abnormal Vital Signs Predict Critical Deterioration in Hospitalized Pediatric Hematology-Oncology and Post-hematopoietic Cell Transplant Patients.	Frontiers in Oncology	2020
32265502	Pre- and post-magnetic resonance imaging of hips and knees for detecting osteonecrosis in children and adolescents undergoing hematopoietic cell transplantation.	Bone Marrow Transplant	2020
31740766	Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution.	Bone Marrow Transplantation	2020
32006482	Ocular Complications in School-Age Children and Adolescents after Allogeneic Bone Marrow Transplantation.	American Journal of Ophthalmology	2020
32395682	Factors Associated with Declining to Participate in a Pediatric Oncology Next Generation Sequencing Study.	JCO Precis Oncol	2020
32103506	Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.	Br J Haematol	2020
32341484	Optimizing lentiviral vector transduction of hematopoietic stem cells for gene therapy.	Gene Ther	2020